Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$144,400.00
May 1, 2018
For-profit organization
Software Platform to support Large Scale Mental Health Organizations
907208
The features and technology implemented under this project will give organizations and health systems the ability to deliver more flexible care, engage patients outside of the traditional clinical setting and provide clearer outcome insights and metrics across different programs, regions and treatment modalities.
$50,000.00
Jun 4, 2018
For-profit organization
Cell Line Testing for Tumor Shrinkage
907704
Tieös Pharmaceuticals is a pre-clinical stage biotech company with the goal of creating novel small molecule inhibitors which target the unique metabolic characteristics of cancer cells.
$30,000.00
Aug 15, 2021
For-profit organization
Youth-Advancing development of AMRT infrastructure and AMRT techniques
977821
Advancing AMRT in both the infrastructural and clinical fronts will enrich the overall health and wellness service landscape in Canada, promote safety and ecotourism, and quality of life for all Canadians.
$50,000.00
Apr 1, 2018
For-profit organization
R&D of Fiber Based Wafer Cookie for Human Markets
901923
This project builds from clinical work initiated by University of Calgary and is focused on the research and development of fiber fortified products that could promote weight management and improved health of humans.
$49,920.00
Jan 1, 2019
For-profit organization
Software Methods for Assessment and Enhancement of Quality of Retinal Fundus Images
919061
Aurteen Inc. is developing software that will automatically identify image-quality issues and attempt to correct them, thereby improving Ophthalmologists’ ability to diagnose clinically-relevant anomalies and issues using retinal images.
$44,327.00
Jan 7, 2019
For-profit organization
PK and tolerability xenograft testing for lead oncology compound
919111
Tieös Pharmaceuticals is a pre-clinical stage biotech company, with the goal of creating novel small molecule inhibitors which target the unique metabolic characteristics of cancer cells.
$50,000.00
Feb 4, 2021
For-profit organization
Multi-language Support for the Winterlight Assessment App
969026
Given the number of
clinical trial sites in different countries across the world, the following languages were identified as top-priorities from
the business perspective: 1) Spanish, 2) French, 3) German.
$71,336.00
Dec 1, 2023
For-profit organization
A New Method for Eliminating Argon Ion Species in ICP-MS to Enable Interference-Free Sample Analysis
1015543
This technology paves the road for a completely new compact ICP-MS technology that can offer rapid, ultra-sensitive, real-time elemental analysis for the first time with significant benefits to several sectors such as environmental, semiconductor, clinical, metals and mining, and geochemical. It will also lead to high paying technology jobs and contribute to Canada's economy through the production, sale, and export of high-tech instruments.
$250,000.00
Apr 1, 2024
For-profit organization
Early Economic Evaluation of Innovative Canadian Life Sciences SME Technology - Extension
1017389
It will undertake a quantitative assessment of the clinical and economic outcomes that might be achieved with the new product, and a determination of whether a healthcare payer will reimburse the product at a price sufficient to generate a return on investment.
$75,000.00
Feb 1, 2025
For-profit organization
Pharmacy SaaS Product - Document Conversion to AI Enabled
1026750
The pilot project will develop an AI agent that customizes user documentation across clinical workflows, reducing administrative burden, improving communication, and enhancing patient care.